References
- Moudi M, Sargazi S, Nia MH, et al. Polymorphism in the 3′-UTR of LIF but not in the ATF6B gene associates with schizophrenia susceptibility: a case-control study and in silico analyses. J Mol Neurosci. 2020.
- Sargazi S, Nia MH, Sheervalilou R, et al. Relationship between single nucleotide polymorphisms of GRHL3 and schizophrenia susceptibility: a preliminary case-control study and bioinformatics analysis. Int J Mol Cell Med. 2020;9(2):154.
- Zou M, Li D, Lv R, et al. Association between two single nucleotide polymorphisms at corresponding microRNA and schizophrenia in a Chinese population. Mol Biol Rep. 2012;39(4):3385–3391.
- Sargazi S, Nia MH, Saravani R, et al. IGF2BP2 polymorphisms as genetic biomarkers for either schizophrenia or type 2 diabetes mellitus: a case-control study. Gene Rep. 2020;20:100680.
- Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320(5875):539–543.
- Lichtermann D, Karbe E, Maier W. The genetic epidemiology of schizophrenia and of schizophrenia spectrum disorders. Eur Arch Psychiat Clin Neurosci. 2000;250(6):304–310.
- Wong AHC, Van Tol HH. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev. 2003;27(3):269–306.
- Schmidt-Kastner R, Van Os J, Esquivel G, et al. An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry. 2012;17(12):1194–1205.
- Ye L, Wei J, Sun Z, et al. Further study of a genetic association between the CLDN5 locus and schizophrenia. Schizophr Res. 2005;75(1):139–141.
- Omidinia E, Mazar FM, Shahamati P, et al. Polymorphism of the CLDN5 gene and Schizophrenia in an Iranian Population. Iran J Public Health. 2014;43(1):79.
- Lu XCM, Williams AJ, Yao C, et al. Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res. 2004;77(6):843–857.
- Kenny E, Cormican P, Furlong S, et al. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol Psychiatry. 2014;19(8):872–879.
- Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397–406.
- Zong L, Zhou L, Hou Y, et al. Genetic and epigenetic regulation on the transcription of GABRB2: genotype-dependent hydroxymethylation and methylation alterations in schizophrenia. J Psychiatr Res. 2017;88:9–17.
- Petryshen T, Middleton F, Tahl A, et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry. 2005;10(12):1074–1088, 1057.
- Lo WS, Lau CF, Xuan Z, et al. Association of SNPs and haplotypes in GABAA receptor beta2 gene with schizophrenia. Mol Psychiatry. 2004;9(6):603–608.
- Zhao C, Wang F, Pun FW, et al. Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disorders. Schizophr Res. 2012;134(2–3):260–266.
- Zhang T, Li J, Yu H, et al. Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium. PLoS One. 2018;13(6):e0198690.
- Black DW, Grant JE. DSM-5® guidebook: the essential companion to the diagnostic and statistical manual of mental disorders. London, England: American Psychiatric Pub; 2014.
- Gaaib JN. Simple salting–out method for genomic DNA extraction from whole blood. Tikrit J Pure Sci. 2011;16(2):9–11.
- Sabarinathan R, Tafer H, Seemann SE, et al. The RNAsnp web server: predicting SNP effects on local RNA secondary structure. Nucleic Acids Res. 2013;41:W475–W479.
- Desmet F-O, Hamroun D, Lalande M, et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37(9):e67.
- Piva F, Giulietti M, Burini AB, et al. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat. 2012;33(1):81–85.
- Dogan RI, Getoor L, Wilbur WJ, et al. SplicePort-an interactive splice-site analysis tool . Nucleic Acids Res. 2007;35:W285–W291.
- Jahantigh D, Hosseinzadeh Colagar A. XRCC5 VNTR, XRCC6-61C > G, and XRCC7 6721G > T gene polymorphisms associated with male infertility risk: evidences from case-control and in silico studies. Int J Endocrinol. 2017;2017:1–16.
- Jahantigh D, Colagar AH, Salimi S. Genetic polymorphisms and haplotypes of the DJ-1 gene promoter associated with the susceptibility to male infertility. J Assist Reprod Genet. 2017;34(12):1673–1682.
- Jahantigh D, Forghani F, Zidanloo SG. Interleukin-23 receptor (IL-23R) gene polymorphisms and haplotypes associated with the risk of preeclampsia: evidence from cross-sectional and in silico studies. J Assist Reprod Genet. 2019;36(7):1523–1536.
- Speir ML, Zweig AS, Rosenbloom KR, et al. The UCSC genome browser database: 2016 update. Nucleic Acids Res. 2016;44(D1):D717–D725.
- Crooks GE, Hon G, Chandonia J-M, et al. WebLogo: a sequence logo generator. Genome Res. 2004;14(6):1188–1190.
- Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265.
- Harper S, Towers-Evans H, MacCabe J. The aetiology of schizophrenia: what have the Swedish Medical Registers taught us? Soc Psychiatry Psychiatr Epidemiol. 2015;50(10):1471–1479.
- Harrison PJ. Recent genetic findings in schizophrenia and their therapeutic relevance. J Psychopharmacol (Oxford). 2015;29(2):85–96.
- Roy SW, Gilbert W. The evolution of spliceosomal introns: patterns, puzzles and progress. Nat Rev Genet. 2006;7(3):211–221.
- Jaillon O, Bouhouche K, Gout J-F, et al. Translational control of intron splicing in eukaryotes. Nature. 2008;451(7176):359–362.
- Pagani F, Baralle FE. Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet. 2004;5(5):389–396.
- Ma D, Whitehead P, Menold M, et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet. 2005;77(3):377–388.
- Jiao Y, Chen R, Ke X, et al. Predictive models for subtypes of autism spectrum disorder based on single-nucleotide polymorphisms and magnetic resonance imaging. Adv Med Sci. 2011;56(2):334–342.
- Kuperman S, Chan G, Kramer J, et al. A GABRA2 polymorphism improves a model for prediction of drinking initiation. Alcohol. 2017;63:1–8.
- Yu Z, Chen J, Shi H, et al. Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. Clin Biochem. 2006;39(3):210–218.
- Ikeda M, Iwata N, Suzuki T, et al. Association analysis of chromosome 5 GABAA receptor cluster in Japanese schizophrenia patients. Biol Psychiatry. 2005;58(6):440–445.
- Rabin RA, George TP. A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. Am J Addict. 2015;24(2):105–116.
- Zhou BT, Zhou QH, Yin JY, et al. Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up. CNS Neurosci Ther. 2012;18(7):566–572.
- Gambardella A, Manna I, Labate A, et al. GABA (B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology. 2003;60(4):560–563.
- Cherlyn SYT, San Woon P, Liu JJ, et al. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci Biobehav Rev. 2010;34(6):958–977.
- Kozak K, Barr MS, George TP. Traits and biomarkers for addiction risk in schizophrenia. Curr Addict Rep. 2017;4(1):14–24.